Wave Life Sciences Cash Flow Statement (2014-2026) | WVE

Cash Flow Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-6.23M-34.79M-37.81M-41.30M-39.00M-43.71M-27.41M-21.10M7.25M-16.28M-31.56M-32.92M-61.78M29.25M-46.88M-50.47M-53.85M-53.18M-26.09M-69.36M
Depreciation and Depletion (Quarter)
1.85M1.78M1.73M1.70M1.64M1.51M1.43M1.29M1.20M1.08M1.04M1.00M0.95M0.91M0.88M0.86M0.86M0.84M0.84M0.86M
Share-based Compensation (Quarter)
5.90M3.73M3.97M6.95M3.37M-2.28M2.75M2.41M2.28M2.35M2.88M3.48M3.53M3.24M4.95M6.20M6.47M7.35M9.06M20.95M
Deferred Taxes (Quarter)
Cash from Operations (Quarter)
-28.18M-7.03M-39.87M-28.82M-25.65M-33.44M85.52M-37.26M-34.46M-33.24M-33.43M-27.47M-46.48M-43.65M-63.04M-46.01M-44.67M-33.78M-59.55M-53.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.55M0.76M0.78M0.81M0.96M0.98M1.00M1.03M1.07M1.10M1.14M1.17M1.21M1.25M1.29M1.33M1.37M1.42M1.46M1.51M
Depreciation & Amortization (CF) (Quarter)
1.85M1.78M1.73M1.70M1.64M1.51M1.43M1.29M1.20M1.08M1.04M1.00M0.95M0.91M0.88M0.86M0.86M0.84M0.84M0.86M
Change in Working Capital
Change in Receivables (Quarter)
-37.50M-22.50M7.00M14.09M-21.09M1.29M-1.29M1.42M-1.42M1.62M8.38M-8.72M-1.28M0.89M
Change in Account Payables (Quarter)
-1.08M-0.23M2.49M0.77M5.07M1.01M-4.67M0.22M0.50M0.19M-1.07M6.11M-5.08M3.46M-2.05M0.28M0.06M1.16M3.29M1.57M
Change in Accured Expenses (Quarter)
1.44M3.50M-7.93M4.16M-0.03M6.50M-9.93M2.81M2.19M4.20M-10.21M4.06M3.46M6.94M-13.27M5.21M3.46M10.08M-13.52M5.20M
Other Working Capital Changes (Quarter)
-0.94M-1.16M0.85M1.09M-5.45M0.11M1.80M0.57M-6.32M-1.55M-1.58M2.98M-6.35M-1.77M-0.12M0.20M-4.85M0.45M0.75M-2.14M
Investing Activities
Capital Expenditures (Quarter)
0.10M0.01M0.21M0.49M0.46M0.20M0.49M0.07M0.20M0.36M0.42M0.05M0.38M0.09M0.17M0.31M0.25M-0.00M0.44M0.88M
Change in Acquisitions & Divestments (Quarter)
25.00M25.04M
Cash from Investing Activities (Quarter)
-0.10M-0.01M-50.21M24.61M-0.50M24.84M-0.49M-0.07M-0.20M-0.36M-0.42M-0.05M-0.38M-0.09M-0.17M-0.31M-0.25M0.00M-0.44M-123.45M
Financing Activities
Other financing activities (Quarter)
0.27M-0.36M0.04M0.14M0.20M0.43M-0.31M0.63M0.35M-0.12M13.87M-11.12M0.44M2.60M2.04M-4.21M0.59M0.33M
Cash from Financing Activities (Quarter)
8.35M33.79M1.32M65.80M0.02M0.06M35.05M1.85M1.67M93.96M14.51M0.65M203.75M34.98M4.16M11.69M32.69M439.69M2.53M0.33M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
8.03M33.79M1.10M50.36M-0.23M-0.01M93.57M14.04M173.90M-173.90M330.91M
Additional items
Exchange Rate Effect (Quarter)
-0.01M-0.08M-0.09M-0.14M-0.08M0.09M-0.02M-0.10M-0.03M0.06M-0.07M-0.08M0.12M-0.10M0.06M0.04M-0.03M-0.06M-0.00M0.12M
Change in Cash (Quarter)
-19.94M26.67M-88.85M61.45M-26.21M-8.45M120.06M-35.58M-33.02M60.42M-19.41M-26.95M157.00M-8.86M-58.99M-34.58M-12.25M405.86M-57.47M-176.58M
Free Cash Flow (Quarter)
-28.28M-7.05M-40.08M-29.31M-26.10M-33.64M85.03M-37.33M-34.66M-33.59M-33.85M-27.52M-46.86M-43.73M-63.20M-46.32M-44.91M-33.77M-59.99M-54.47M
Net Cash Flow (Quarter)
-19.93M26.75M-88.77M61.59M-26.13M-8.54M120.09M-35.48M-32.98M60.37M-19.34M-26.87M156.88M-8.75M-59.05M-34.62M-12.22M405.92M-57.46M-176.71M